Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells

被引:0
|
作者
Cobbs, CS
Whisenhunt, TR
Wesemann, DR
Harkins, LE
Van Meir, EG
Samanta, M
机构
[1] Univ Alabama, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA
[2] Vet Affairs Med Ctr, Surg Serv, Birmingham, AL USA
[3] Univ Alabama, Med Scientist Training Program, Birmingham, AL USA
[4] Emory Univ, Sch Med, Mol Neurooncol Lab, Atlanta, GA USA
[5] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant gliomas are the most common primary brain tumors in adults, and the most malignant form, glioblastoma multiforme (GBM), is usually rapidly fatal. Most GBMs do not have p53 mutations, although the p53 tumor suppressor pathway appears to be inactivated. GBMs grow in a hypoxic and inflammatory microenviromnent, and increased levels of the free radicals nitric oxide (NO) and superoxide (O-2 radical anion,) occur in these malignancies in vivo. Peroxynitrite (ONOO-) is a highly reactive molecule produced by excess NO and W. that can posttranslationally modify and inactivate proteins, especially zinc finger transcription factors such as p53. We demonstrated previously that GBMs have evidence of tyrosine nitration, the "footprint" of per oxymtrite-mediated protein modification in vivo, and that peroxyrtitrite could inhibit the specific DNA binding ability of wild-type p53 protein in glioma cells in vitro. Here we show that both authentic peroxynitrite and SIN-1 (3-morpholinosydnonimine hydrochloride), a molecule that decomposes into NO and O-2 radical anion to form peroxynitrite, can inhibit wild-type p53 function in malignant glioma cells. Concentrations of peroxynitrite associated with a tumor inflammatory environment caused dysregulation. of wild-type p53 transcriptional activity and downstream p21(WAF1) expression.
引用
收藏
页码:8670 / 8673
页数:4
相关论文
共 50 条
  • [41] Contribution of the p53 pathway in cancers that carry wild-type p53
    Ohki, Rieko
    CANCER SCIENCE, 2022, 113 : 1232 - 1232
  • [42] Induction of differentiation by wild-type p53 gene in a human glioma cell line
    Takashi Kokunai
    Atsufumi Kawamura
    Norihiko Tamaki
    Journal of Neuro-Oncology, 1997, 32 : 125 - 133
  • [43] Gene therapy of malignant gliomas: Adenovirus-mediated wild-type p53 expression induces widespread apoptosis of human glioma cells independently of endogenous p53 status
    Li, HW
    Lochmuller, H
    Seth, P
    Karpati, G
    Nalbantoglu, J
    NEUROLOGY, 1997, 48 (03) : 1026 - 1026
  • [44] Wild-type p53 activates SAP expression in lymphoid cells
    N Nagy
    M Takahara
    J Nishikawa
    J C Bourdon
    L L Kis
    G Klein
    E Klein
    Oncogene, 2004, 23 : 8563 - 8570
  • [45] Induction of differentiation by wild-type p53 gene in a human glioma cell line
    Kokunai, T
    Kawamura, A
    Tamaki, N
    JOURNAL OF NEURO-ONCOLOGY, 1997, 32 (02) : 125 - 133
  • [46] Wild-type p53 activates SAP expression in lymphoid cells
    Nagy, N
    Takahara, M
    Nishikawa, J
    Bourdon, JC
    Kis, LL
    Klein, G
    Klein, E
    ONCOGENE, 2004, 23 (53) : 8563 - 8570
  • [47] Inactivation of Wild-Type p53 by Asparagine Endopeptidase in Glioblastoma: An Opportunity to Target the "Undruggable"
    Manfredi, James J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (04): : 327 - 329
  • [48] Regulation of protein synthesis by inducible wild-type p53 in human lung carcinoma cells
    Tilleray, V
    Constantinou, C
    Clemens, MJ
    FEBS LETTERS, 2006, 580 (07): : 1766 - 1770
  • [49] No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis
    Blok, P
    Craanen, ME
    Dekker, W
    Offerhaus, GJA
    Tytgat, GNJ
    JOURNAL OF PATHOLOGY, 1998, 186 (01): : 36 - 40
  • [50] ADP-ribosylation of p53 tumor suppressor protein: Mutant but not wild-type p53 is modified
    WesierskaGadek, J
    BugajskaSchretter, A
    Cerni, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1996, 62 (01) : 90 - 101